Cedelizumab, CAS 156586-90-2

Product Description: Cedelizumab (RWJ 49004) is a IgG4 monoclonal antibody targeting CD4. Cedelizumab has immunosuppressant properties[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]WHO Drug Information Vol. 12, No. 1, 1998.

CAS Number: 156586-90-2

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Others

• SKU: MEXHY-P99495-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99495-5
• Package Unit: 5mg
• Quantity Unit: STK
• Conjugate: Unconjugated